Ieq Capital LLC Buys New Shares in Nu Skin Enterprises, Inc. $NUS

Key Points

• Ieq Capital LLC has invested approximately $279,000 in Nu Skin Enterprises by acquiring 38,461 shares, representing 0.08% of the company.
• Several institutional investors, including Two Sigma Investments LP and Man Group plc, significantly increased their stakes in Nu Skin Enterprises in the last quarter.
• Nu Skin reported quarterly earnings of $0.43 per share, surpassing estimates and showing a net margin of 6.20%, while also announcing a quarterly dividend of $0.06 per share.

Ieq Capital LLC bought a new position in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 38,461 shares of the company's stock, valued at approximately $279,000. Ieq Capital LLC owned 0.08% of Nu Skin Enterprises as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of NUS. Prescott Group Capital Management L.L.C. boosted its position in Nu Skin Enterprises by 142.7% during the first quarter. Prescott Group Capital Management L.L.C. now owns 1,394,608 shares of the company's stock valued at $10,125,000 after purchasing an additional 819,972 shares during the last quarter. Pacer Advisors Inc. bought a new position in Nu Skin Enterprises during the first quarter valued at about $4,577,000. Two Sigma Advisers LP raised its holdings in Nu Skin Enterprises by 61.2% during the fourth quarter. Two Sigma Advisers LP now owns 944,000 shares of the company's stock valued at $6,504,000 after buying an additional 358,400 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Nu Skin Enterprises by 47.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,052,384 shares of the company's stock valued at $7,640,000 after buying an additional 336,807 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. raised its holdings in Nu Skin Enterprises by 15.5% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 2,251,352 shares of the company's stock valued at $15,512,000 after buying an additional 301,295 shares in the last quarter. Institutional investors and hedge funds own 82.84% of the company's stock.

Insider Transactions at Nu Skin Enterprises

In other news, Director Laura Nathanson sold 6,489 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $12.22, for a total transaction of $79,295.58. Following the completion of the transaction, the director directly owned 33,149 shares in the company, valued at $405,080.78. This represents a 16.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Daniel W. Campbell sold 23,391 shares of the firm's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $12.10, for a total transaction of $283,031.10. Following the completion of the sale, the director owned 53,375 shares of the company's stock, valued at $645,837.50. This trade represents a 30.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 58,926 shares of company stock worth $711,364 in the last three months. Insiders own 2.00% of the company's stock.

Nu Skin Enterprises Trading Up 3.7%

NUS stock traded up $0.43 during trading on Thursday, hitting $11.95. The company had a trading volume of 178,938 shares, compared to its average volume of 644,679. The stock has a market cap of $591.38 million, a price-to-earnings ratio of 5.95 and a beta of 0.92. Nu Skin Enterprises, Inc. has a 12 month low of $5.32 and a 12 month high of $12.40. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. The firm has a 50-day moving average price of $10.13 and a 200-day moving average price of $8.24.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.25 by $0.18. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. The company had revenue of $386.14 million during the quarter, compared to analysts' expectations of $376.68 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. As a group, analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 10th. Stockholders of record on Friday, August 29th were paid a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date was Friday, August 29th. Nu Skin Enterprises's dividend payout ratio is currently 11.94%.

Analyst Ratings Changes

NUS has been the topic of a number of recent analyst reports. Zacks Research upgraded Nu Skin Enterprises to a "hold" rating in a research note on Tuesday, August 12th. Wall Street Zen lowered Nu Skin Enterprises from a "strong-buy" rating to a "buy" rating in a research note on Friday, September 5th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $6.88.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.